Your search returned 3 results.

Results
	1.	A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML. [electronic resource] by Kats, L M Vervoort, S J Cole, R Rogers, A J Gregory, G P Vidacs, E Li, J Nagaraja, R Yen, K E Johnstone, R W Producer: 20180620 In: Leukemia vol. 31 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	CDK9 inhibition by dinaciclib potently suppresses Mcl-1 to induce durable apoptotic responses in aggressive MYC-driven B-cell lymphoma in vivo. [electronic resource] by Gregory, G P Hogg, S J Kats, L M Vidacs, E Baker, A J Gilan, O Lefebure, M Martin, B P Dawson, M A Johnstone, R W Shortt, J Producer: 20150825 In: Leukemia vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Preclinical screening of histone deacetylase inhibitors combined with ABT-737, rhTRAIL/MD5-1 or 5-azacytidine using syngeneic Vk*MYC multiple myeloma. [electronic resource] by Matthews, G M Lefebure, M Doyle, M A Shortt, J Ellul, J Chesi, M Banks, K M Vidacs, E Faulkner, D Atadja, P Bergsagel, P L Johnstone, R W Producer: 20140312 In: Cell death & disease vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search